Target intelligence / Profile preview

Ribosomal protein S20 pseudogene 25 (RPS20P25)

Target
RPS20P25
Molecular classification
Other (Pseudogene)
01

Overview

**Ribosomal protein S20 pseudogene 25 (RPS20P25)** is a processed pseudogene corresponding to the gene encoding ribosomal protein S20. It is not believed to encode a functional protein, nor does it have any established biological function or disease association. This pseudogene is part of a family of non-coding gene copies that result from retrotransposition events, commonly found throughout the human genome for many ribosomal protein genes. There is no evidence that RPS20P25 is a functional or druggable target, nor does it have relevance as a biomarker or in therapeutic contexts[1][2][7].\n\n**Key points:**\n- RPS20P25 is strictly classified as a pseudogene and does not produce any active protein[1][2][7].\n- There are no known biological roles, disease associations, or drug interactions.\n- Not a therapeutic target; inclusion as a target is a likely error or confusion with its parent gene, RPS20.\n- The canonical ribosomal protein S20 (RPS20) is a structural component of the 40S ribosomal subunit involved in protein synthesis[3][5], but pseudogenes like RPS20P25 are generally nonfunctional duplicates.\n\nIf a true biological target is intended, refer to the canonical parent gene, **RPS20 (Ribosomal protein S20)**, instead.

Other names
RPS20_13_989RPS20P25

Beyond the preview

Go deeper on Ribosomal protein S20 pseudogene 25 (RPS20P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S20 pseudogene 25 (RPS20P25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call